About 169,000 results
Open links in new tab
Lilly's donanemab slowed Alzheimer's disease progression in …
Lilly.com | Eli Lilly and Company
Lilly's Kisunla™ (donanemab-azbt) Approved in Japan for the …
All News - Eli Lilly and Company
News Release - Eli Lilly and Company
Eli Lilly’s stock soars toward best day in 23 years after strong ...
Alzheimer's drug donanemab shows positive results, Eli Lilly ... - CNBC
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Lilly hits record high after Mounjaro fuels forecast raise, rival data
Eli Lilly Stock Surges as Weight Loss Drugs Continue to Fuel Growth